NCT01161472 - A Study to Assess the Cognitive Effects of Fesoterodine in Elderly Subjects | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

September 30, 2010

Study Completion Date

September 30, 2010

Conditions

Healthy

Interventions

DRUG

4mg fesoterodine

4mg tablet once daily for 6 days

DRUG

8mg fesoterodine

4mg tablet once daily for 3 days followed by 8mg tablet once daily for 3 days

DRUG

alprazolam 1mg

1mg tablet once on last day of treatment period at clinic

DRUG

Placebo

Placebo tablet for fesoterodine once daily for 6 days and placebo tablet for alprazolam once on last day of treatment period at clinic

Trial Locations (2)

Pfizer Investigational Site, Overland Park

Pfizer Investigational Site, Overland Park